The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 01 2020
Historique:
received: 23 09 2019
accepted: 03 01 2020
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 15 12 2020
Statut: epublish

Résumé

Several studies have linked the E3 ubiquitin ligase TRIP12 (Thyroid hormone Receptor Interacting Protein 12) to the cell cycle. However, the regulation and the implication of this protein during the cell cycle are largely unknown. In this study, we show that TRIP12 expression is regulated during the cell cycle, which correlates with its nuclear localization. We identify an euchromatin-binding function of TRIP12 mediated by a N-terminal intrinsically disordered region. We demonstrate the functional implication of TRIP12 in the mitotic entry by controlling the duration of DNA replication that is independent from its catalytic activity. We also show the requirement of TRIP12 in the mitotic progression and chromosome stability. Altogether, our findings show that TRIP12 is as a new chromatin-associated protein with several implications in the cell cycle progression and in the maintenance of genome integrity.

Identifiants

pubmed: 31964993
doi: 10.1038/s41598-020-57762-9
pii: 10.1038/s41598-020-57762-9
pmc: PMC6972862
doi:

Substances chimiques

Carrier Proteins 0
Euchromatin 0
TRIP12 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

789

Références

Chen, D., Yoon, J.-B. & Gu, W. Reactivating the ARF-p53 axis in AML cells by targeting ULF. Cell Cycle Georget. Tex 9, 2946–2951 (2010).
Xie, Y. & Varshavsky, A. UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis. Nat. Cell Biol. 4, 1003–1007 (2002).
pubmed: 12447385 doi: 10.1038/ncb889
Ju, D., Wang, X., Xu, H. & Xie, Y. The armadillo repeats of the Ufd4 ubiquitin ligase recognize ubiquitin-fusion proteins. FEBS Lett. 581, 265–270 (2007).
pubmed: 17204268 doi: 10.1016/j.febslet.2006.12.024 pmcid: 17204268
Keppler, B. R. & Archer, T. K. Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex. J. Biol. Chem. 285, 35665–35674 (2010).
pubmed: 20829358 pmcid: 2975191 doi: 10.1074/jbc.M110.173997
Park, Y., Yoon, S. K. & Yoon, J.-B. TRIP12 functions as an E3 ubiquitin ligase of APP-BP1. Biochem. Biophys. Res. Commun. 374, 294–298 (2008).
pubmed: 18627766 doi: 10.1016/j.bbrc.2008.07.019 pmcid: 18627766
Gudjonsson, T. et al. TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150, 697–709 (2012).
pubmed: 22884692 doi: 10.1016/j.cell.2012.06.039
Chen, D. et al. Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression. Mol. Cell 51, 46–56 (2013).
pubmed: 23747016 doi: 10.1016/j.molcel.2013.05.006
Kweon, S.-M. et al. An Adversarial DNA N6-Methyladenine-Sensor Network Preserves Polycomb Silencing. Mol. Cell https://doi.org/10.1016/j.molcel.2019.03.018 (2019).
pubmed: 30982744 pmcid: 6591016 doi: 10.1016/j.molcel.2019.03.018
Hanoun, N. et al. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation. J. Biol. Chem. 289, 35593–35604 (2014).
pubmed: 25355311 pmcid: 4271242 doi: 10.1074/jbc.M114.620104
Kajiro, M. et al. The E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesis. PloS One 6, e25871 (2011).
pubmed: 22028794 pmcid: 3196520 doi: 10.1371/journal.pone.0025871
Chen, D. et al. regulation in oncogenic stress-mediated p53 responses. Nature 464, 624–627 (2010).
pubmed: 20208519 pmcid: 3737736 doi: 10.1038/nature08820
Cai, J.-B. et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatol. Baltim. Md. 61, 1603–1614 (2015).
doi: 10.1002/hep.27682
Wang, L. et al. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects. Oncogene 36, 820–828 (2017).
pubmed: 27425591 doi: 10.1038/onc.2016.250
O’Roak, B. J. et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat. Commun. 5, 5595 (2014).
pubmed: 25418537 pmcid: 4249945 doi: 10.1038/ncomms6595
Bramswig, N. C. et al. Identification of new TRIP12 variants and detailed clinical evaluation of individuals with non-syndromic intellectual disability with or without autism. Hum. Genet. 136, 179–192 (2017).
pubmed: 27848077 doi: 10.1007/s00439-016-1743-x
Siddiqui, K., On, K. F. & Diffley, J. F. X. Regulating DNA replication in eukarya. Cold Spring Harb. Perspect. Biol. 5 (2013).
Lau, Y. F. & Arrighi, F. E. Studies of mammalian chromosome replication. II. Evidence for the existence of defined chromosome replicating units. Chromosoma 83, 721–741 (1981).
pubmed: 7028418 doi: 10.1007/BF00328530
Dunphy, W. G., Brizuela, L., Beach, D. & Newport, J. The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell 54, 423–431 (1988).
pubmed: 3293802 doi: 10.1016/0092-8674(88)90205-X
Parker, L. L. & Piwnica-Worms, H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257, 1955–1957 (1992).
pubmed: 1384126 doi: 10.1126/science.1384126
McLean, J. R., Chaix, D., Ohi, M. D. & Gould, K. L. State of the APC/C: organization, function, and structure. Crit. Rev. Biochem. Mol. Biol. 46, 118–136 (2011).
pubmed: 21261459 pmcid: 4856037 doi: 10.3109/10409238.2010.541420
Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379–393 (2007).
pubmed: 17426725 doi: 10.1038/nrm2163
Pesin, J. A. & Orr-Weaver, T. L. Regulation of APC/C activators in mitosis and meiosis. Annu. Rev. Cell Dev. Biol. 24, 475–499 (2008).
pubmed: 18598214 pmcid: 4070676 doi: 10.1146/annurev.cellbio.041408.115949
Ganem, N. J. & Pellman, D. Linking abnormal mitosis to the acquisition of DNA damage. J. Cell Biol. 199, 871–881 (2012).
pubmed: 23229895 pmcid: 3518222 doi: 10.1083/jcb.201210040
Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012).
pubmed: 22258507 pmcid: 3271137 doi: 10.1038/nature10802
Aviner, R., Shenoy, A., Elroy-Stein, O. & Geiger, T. Uncovering Hidden Layers of Cell Cycle Regulation through Integrative Multi-omic Analysis. PLoS Genet. 11, e1005554 (2015).
pubmed: 26439921 pmcid: 4595013 doi: 10.1371/journal.pgen.1005554
van der Lee, R. et al. Classification of intrinsically disordered regions and proteins. Chem. Rev. 114, 6589–6631 (2014).
pubmed: 24773235 pmcid: 4095912 doi: 10.1021/cr400525m
Sabari, B. R. et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science 361 (2018).
Pines, J. & Hunter, T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58, 833–846 (1989).
pubmed: 2570636 doi: 10.1016/0092-8674(89)90936-7
Enders, G. H. Gauchos and ochos: a Wee1-Cdk tango regulating mitotic entry. Cell Div. 5, 12 (2010).
pubmed: 20465818 pmcid: 2886006 doi: 10.1186/1747-1028-5-12
Lindqvist, A., van Zon, W., Karlsson Rosenthal, C. & Wolthuis, R. M. F. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biol. 5, e123 (2007).
pubmed: 17472438 pmcid: 1858714 doi: 10.1371/journal.pbio.0050123
Coverley, D., Laman, H. & Laskey, R. A. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat. Cell Biol. 4, 523–528 (2002).
pubmed: 12080347 doi: 10.1038/ncb813
Li, C., Andrake, M., Dunbrack, R. & Enders, G. H. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol. Cell. Biol. 30, 116–130 (2010).
pubmed: 19858290 doi: 10.1128/MCB.01876-08 pmcid: 19858290
den Elzen, N. & Pines, J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J. Cell Biol. 153, 121–136 (2001).
doi: 10.1083/jcb.153.1.121
De Boer, L. et al. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27, 4261–4268 (2008).
pubmed: 18372919 doi: 10.1038/onc.2008.74 pmcid: 18372919
Whitfield, M. L. et al. Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors. Mol. Biol. Cell 13, 1977–2000 (2002).
pubmed: 12058064 pmcid: 117619 doi: 10.1091/mbc.02-02-0030
Dobson, T., Chen, J. & Krushel, L. A. Dysregulating IRES-Dependent Translation Contributes to Overexpression of Oncogenic Aurora A Kinase. Mol. Cancer Res. 11, 887–900 (2013).
pubmed: 23661421 pmcid: 4109694 doi: 10.1158/1541-7786.MCR-12-0707
Chen, W., Smeekens, J. M. & Wu, R. Systematic study of the dynamics and half-lives of newly synthesized proteins in human cells. Chem. Sci. 7, 1393–1400 (2016).
pubmed: 29910897 doi: 10.1039/C5SC03826J pmcid: 29910897
Ma, H. et al. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc. Natl. Acad. Sci. USA 109, 4828–4833 (2012).
pubmed: 22411829 doi: 10.1073/pnas.1116349109
Petrone, A., Adamo, M. E., Cheng, C. & Kettenbach, A. N. Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics. Mol. Cell. Proteomics MCP 15, 2448–2461 (2016).
pubmed: 27134283 doi: 10.1074/mcp.M116.059394 pmcid: 27134283
Dyson, H. J. & Wright, P. E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197–208 (2005).
pubmed: 15738986 doi: 10.1038/nrm1589
Peng, Z. & Kurgan, L. High-throughput prediction of RNA, DNA and protein binding regions mediated by intrinsic disorder. Nucleic Acids Res. 43, e121 (2015).
pubmed: 26109352 pmcid: 4605291 doi: 10.1093/nar/gkv585
Wang, C., Uversky, V. N. & Kurgan, L. Disordered nucleiome: Abundance of intrinsic disorder in the DNA- and RNA-binding proteins in 1121 species from Eukaryota, Bacteria and Archaea. Proteomics 16, 1486–1498 (2016).
pubmed: 27037624 doi: 10.1002/pmic.201500177
Maréchal, A. et al. PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry. Mol. Cell 53, 235–246 (2014).
pubmed: 24332808 doi: 10.1016/j.molcel.2013.11.002
Braden, W. A., McClendon, A. K. & Knudsen, E. S. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. Oncogene 27, 7083–7093 (2008).
pubmed: 18776921 doi: 10.1038/onc.2008.319
Demeret, C., Vassetzky, Y. & Méchali, M. Chromatin remodelling and DNA replication: from nucleosomes to loop domains. Oncogene 20, 3086–3093 (2001).
pubmed: 11420724 doi: 10.1038/sj.onc.1204333
Cao, Q. et al. The central role of EED in the orchestration of polycomb group complexes. Nat. Commun. 5, 3127 (2014).
pubmed: 24457600 pmcid: 4073494 doi: 10.1038/ncomms4127
Oliviero, G. et al. Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells. Mol. Cell. Proteomics MCP 15, 3450–3460 (2016).
pubmed: 27634302 doi: 10.1074/mcp.M116.062240
Abe, S. et al. The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II. Genes Dev. 25, 863–874 (2011).
pubmed: 21498573 pmcid: 3078710 doi: 10.1101/gad.2016411
Wu, R. S., Kohn, K. W. & Bonner, W. M. Metabolism of ubiquitinated histones. J. Biol. Chem. 256, 5916–5920 (1981).
pubmed: 6263895
Arora, M. et al. Promoters active in interphase are bookmarked during mitosis by ubiquitination. Nucleic Acids Res. 40, 10187–10202 (2012).
pubmed: 22941662 pmcid: 3488253 doi: 10.1093/nar/gks820
Giunta, S., Belotserkovskaya, R. & Jackson, S. P. DNA damage signaling in response to double-strand breaks during mitosis. J. Cell Biol. 190, 197–207 (2010).
pubmed: 20660628 pmcid: 2930281 doi: 10.1083/jcb.200911156
Nakajima, D. et al. Preparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method. DNA Res. Int. J. Rapid Publ. Rep. Genes Genomes 12, 257–267 (2005).
Torrisani, J. et al. let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 20, 831–44 (2009).
pubmed: 19323605 doi: 10.1089/hum.2008.134
Dosztányi, Z., Csizmók, V., Tompa, P. & Simon, I. The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J. Mol. Biol. 347, 827–839 (2005).
pubmed: 15769473 doi: 10.1016/j.jmb.2005.01.071
Linding, R., Russell, R. B., Neduva, V. & Gibson, T. J. GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res. 31, 3701–3708 (2003).
pubmed: 12824398 pmcid: 169197 doi: 10.1093/nar/gkg519
Linding, R. et al. Protein disorder prediction: implications for structural proteomics. Struct. Lond. Engl. 1993 11, 1453–1459 (2003).

Auteurs

D Larrieu (D)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

M Brunet (M)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

C Vargas (C)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

N Hanoun (N)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

L Ligat (L)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

L Dagnon (L)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

H Lulka (H)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

R M Pommier (RM)

Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, 69008, France.

J Selves (J)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

B E Jády (BE)

Laboratoire de Biologie Moléculaire Eucaryote du CNRS, UMR5099, Centre de Biologie Intégrative, Université Toulouse III-Paul Sabatier, Toulouse, Cedex 9, France.

L Bartholin (L)

Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, 69008, France.

P Cordelier (P)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

M Dufresne (M)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.

J Torrisani (J)

Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France. jerome.torrisani@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH